Sandra Robrecht
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 96
- Chronic Lymphocytic Leukemia Research 96
-
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Michael J. Hallek (47 shared papers)Kirsten Fischer (45 shared papers)Stephan Stilgenbauer (37 shared papers)Barbara F. Eichhorst (36 shared papers)Jasmin Bahlo (24 shared papers)Matthias Ritgen (20 shared papers)Paula Cramer (19 shared papers)Eugen Tausch (24 shared papers)
- Journals
- Blood (34 papers)Leukemia (15 papers)Hematological Oncology (12 papers)Haematologica (5 papers)HemaSphere (4 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Sandra Robrecht
97 papers receiving 3.1k citations
Sandra Robrecht's Hit Papers
Peers
Comparison fields: 5 of 48
- Genetics 2.5k
- Pathology and Forensic Medicine 95
- Hematology 61
- Oncology 47
- Molecular Biology 119
Countries citing papers authored by Sandra Robrecht
This map shows the geographic impact of Sandra Robrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Robrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Robrecht more than expected).
Fields of papers citing papers by Sandra Robrecht
This network shows the impact of papers produced by Sandra Robrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Robrecht. The network helps show where Sandra Robrecht may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Robrecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions Hit paper breakdown → | 2019 | 664 |
| 2 | Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial Hit paper breakdown → | 2020 | 267 |
| 3 | First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia Hit paper breakdown → | 2023 | 204 |
| 4 | 2016 | 149 | |
| 5 | 2021 | 113 | |
| 6 | 2020 | 96 | |
| 7 | 2018 | 95 | |
| 8 | 2020 | 87 | |
| 9 | 2021 | 76 | |
| 10 | Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study Hit paper breakdown → | 2024 | 70 |
| 11 | 2023 | 68 | |
| 12 | 2019 | 64 | |
| 13 | 2020 | 58 | |
| 14 | 2017 | 47 | |
| 15 | 2024 | 42 | |
| 16 | 2023 | 41 | |
| 17 | 2020 | 39 | |
| 18 | 2022 | 38 | |
| 19 | 2018 | 37 | |
| 20 | 2020 | 37 |
About Sandra Robrecht
Sandra Robrecht is a scholar working on Genetics, Infectious Diseases, Immunology, Molecular Biology and Nuclear Energy and Engineering, having authored 102 papers that have together received 3.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (96 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Nuclear Structure and Function (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Genetics (2.5k citations), Pathology and Forensic Medicine (95 citations), Hematology (61 citations), Oncology (47 citations) and Molecular Biology (119 citations). Sandra Robrecht has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Michael J. Hallek, Kirsten Fischer, Stephan Stilgenbauer, Barbara F. Eichhorst, Jasmin Bahlo, Matthias Ritgen, Paula Cramer, Eugen Tausch, Anna‐Maria Fink and Julia von Tresckow. Their work appears in journals such as Blood, Leukemia, Hematological Oncology, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.